Antibodies are Y-shaped immunoglobulins composed of heavy and light chains, with antigen-binding (Fab) and effector (Fc) regions . If SPAC27D7.02c were characterized, its structure would typically include:
Heavy chains: Determining class (IgG, IgA, IgM) and subclass (e.g., IgG1, IgG4).
Light chains: κ or λ chains, critical for antigen specificity.
Epitope binding: Target antigen(s) and binding affinity (e.g., KD values).
| Parameter | Hypothetical Example (If SPAC27D7.02c Were Characterized) |
|---|---|
| Antibody Class | IgG1 |
| Light Chain Type | κ |
| Target Antigen | Hypothetical protein X |
| Binding Affinity | 10 nM (similar to high-affinity monoclonals) |
Antibodies are validated across techniques like flow cytometry, immunohistochemistry (IHC), and bioassays. For SPAC27D7.02c, typical experimental data might include:
Flow cytometry: Staining efficiency in cell lines (e.g., MCF-7) .
IHC: Localization in tissues (e.g., cytoplasmic or membrane staining) .
Neutralization assays: Inhibition of target protein function .
The global antibody market reached $5.33 billion in 2027, driven by oncology and infectious disease research . If SPAC27D7.02c were commercialized, it might align with trends in:
| Market Segment | Relevance to SPAC27D7.02c |
|---|---|
| Primary Antibodies | Core detection reagent |
| Therapeutic Use | Potential neutralization |
KEGG: spo:SPAC27D7.02c
SPAC27D7.02c is a GRIP domain-containing protein specific to Schizosaccharomyces pombe (fission yeast). The protein (UniProt accession O42657) plays a significant role in cellular function within this model organism. As a GRIP domain protein, it likely participates in Golgi trafficking and membrane organization, which are fundamental cellular processes conserved across eukaryotes. Studying this protein contributes to our understanding of membrane trafficking pathways in S. pombe and potentially provides insights into similar pathways in higher eukaryotes.
The significance of SPAC27D7.02c in S. pombe research stems from its specificity to this organism, making it valuable for studying species-specific adaptations in membrane organization and trafficking. While commercial antibodies are available for this protein (such as CSB-PA522111XA01SXV), researchers should carefully validate these reagents for their specific applications .
Validation of SPAC27D7.02c antibody specificity requires a multi-step approach:
Western blot analysis: Compare protein detection between wild-type and SPAC27D7.02c deletion strains. A specific antibody will show a band at the expected molecular weight in wild-type samples that is absent in deletion strains.
Immunoprecipitation followed by mass spectrometry: Perform IP experiments and analyze the precipitated proteins by mass spectrometry to confirm that SPAC27D7.02c is the predominant protein pulled down.
Epitope tagging validation: Create a strain with epitope-tagged SPAC27D7.02c (e.g., with HA or GFP) and perform parallel detection with both anti-tag and anti-SPAC27D7.02c antibodies to confirm co-localization.
Immunofluorescence specificity controls: Include negative controls (deletion strains) and positive controls (overexpression strains) when performing immunofluorescence to verify signal specificity.
Cross-reactivity assessment: Test the antibody against lysates from related yeasts (e.g., S. cerevisiae) to confirm the absence of cross-reactivity with similar proteins, as expected for a species-specific protein .
For optimal immunofluorescence detection of SPAC27D7.02c in S. pombe, consider the following protocol:
Fixation options:
3.7% formaldehyde for 30 minutes at room temperature preserves most cellular structures
For Golgi proteins like SPAC27D7.02c (GRIP domain), a combination of 3% paraformaldehyde and 0.2% glutaraldehyde may provide better ultrastructural preservation
Permeabilization methods:
1.2M sorbitol with 0.1% Triton X-100 for 5 minutes (gentler approach)
70% ethanol for 30 minutes at -20°C (stronger permeabilization)
Critical considerations:
Test multiple fixation and permeabilization combinations, as GRIP domain proteins may be sensitive to certain fixatives
Include controls with known Golgi markers to verify proper preservation of Golgi structure
Compare results with live-cell imaging of fluorescently tagged SPAC27D7.02c to ensure fixation doesn't disrupt native localization
For detailed protocols on S. pombe immunostaining, researchers should adapt methods from established cell biology work while optimizing specifically for GRIP domain proteins.
To study protein interactions of SPAC27D7.02c in S. pombe, several approaches can be employed:
Co-immunoprecipitation (Co-IP):
Prepare S. pombe cell lysates under non-denaturing conditions using gentle detergents (0.5-1% NP-40 or 0.5% Triton X-100)
Pre-clear lysates with Protein A/G beads
Incubate with SPAC27D7.02c antibody (typically 2-5 μg per 1 mg total protein)
Capture complexes with Protein A/G beads
Wash stringently to remove non-specific interactions
Elute bound proteins and analyze by Western blot or mass spectrometry
Proximity-based labeling:
Create S. pombe strains expressing SPAC27D7.02c fused to BioID or TurboID
Induce proximity labeling with biotin
Purify biotinylated proteins using streptavidin
Identify interacting proteins by mass spectrometry
Validate key interactions using SPAC27D7.02c antibody in reciprocal Co-IP experiments
Yeast two-hybrid screening:
Use SPAC27D7.02c as bait to screen for interacting partners
Validate positive interactions in vivo using SPAC27D7.02c antibody for Co-IP confirmation
When analyzing results, consider that GRIP domain proteins typically interact with Golgi-associated proteins and small GTPases. The BioGRID database contains information on protein interactions in S. pombe that may provide potential candidates for validation .
Common challenges and their solutions for Western blot detection of SPAC27D7.02c include:
Solution: Optimize protein extraction using specialized buffers containing stronger detergents (1-2% SDS) to ensure complete extraction of membrane-associated GRIP domain proteins
Increase antibody concentration (1:500 to 1:100 dilutions may be necessary)
Extend primary antibody incubation to overnight at 4°C
Use enhanced chemiluminescence (ECL) substrates with higher sensitivity
Solution: Increase blocking stringency (5% BSA instead of 5% milk)
Add 0.1-0.5% Tween-20 to washing buffers
Perform antigen pre-absorption of the antibody
Use S. pombe SPAC27D7.02c deletion strain lysate as a negative control
Solution: Standardize protein extraction protocols
Include loading controls specific for S. pombe (e.g., α-tubulin)
Consider using PVDF membranes instead of nitrocellulose for better protein retention
Prepare fresh lysates for each experiment, as GRIP domain proteins may degrade during storage
Data analysis recommendations:
Perform densitometry analysis using ImageJ or similar software
Always normalize SPAC27D7.02c signals to loading controls
Include biological replicates (n≥3) for statistical validation
Consider differences in protein expression across growth phases and stresses
Discrepancies between immunofluorescence and biochemical data for SPAC27D7.02c may arise due to several factors:
Common discrepancies and resolution strategies:
Different subcellular localization patterns vs. biochemical fractionation results:
Perform sequential cell fractionation with increasing detergent strengths
Use both N- and C-terminal tagged versions of SPAC27D7.02c to rule out tag interference
Compare live-cell imaging with fixed-cell immunofluorescence
Isolate Golgi fractions using density gradient centrifugation and analyze SPAC27D7.02c distribution
Protein abundance differences between methods:
Quantify absolute protein levels using quantitative Western blot with recombinant standards
Perform flow cytometry to measure cellular heterogeneity in protein expression
Use single-molecule detection methods to establish detection thresholds
Protein modification detection discrepancies:
Employ phospho-specific antibodies if phosphorylation is suspected
Use 2D gel electrophoresis to separate protein isoforms
Apply mass spectrometry to identify post-translational modifications
Integrative analysis approach:
Create a composite model incorporating data from multiple techniques
Use statistical methods to weight evidence from different experimental approaches
Consider dynamic changes in protein localization during cell cycle or stress responses
Compare results with other GRIP domain proteins in S. pombe to identify conserved patterns
Investigating Golgi dynamics during the S. pombe cell cycle using SPAC27D7.02c antibody requires sophisticated experimental design:
Synchronization and time-course analysis:
Synchronize S. pombe cells using cdc25-22 temperature-sensitive mutants or nitrogen starvation/release
Collect samples at regular intervals (every 20 minutes through a 3-4 hour cycle)
Perform dual immunofluorescence with SPAC27D7.02c antibody and cell cycle markers
Quantify changes in Golgi morphology, number, and distribution
Live-cell imaging complemented with fixed-cell analysis:
Create strains expressing fluorescently-tagged cell cycle markers
Perform time-lapse imaging with fixed timepoints for antibody staining
Analyze correlation between cell cycle stage and SPAC27D7.02c localization/abundance
Cell cycle-specific protein interactions:
Synchronize cells and collect at specific cell cycle stages
Perform immunoprecipitation with SPAC27D7.02c antibody
Identify cycle-specific interaction partners by mass spectrometry
Validate interactions with candidate proteins using proximity ligation assays
Analysis framework:
Quantify Golgi fragmentation/assembly using automated image analysis
Correlate SPAC27D7.02c distribution with microtubule organization
Compare Golgi inheritance patterns between mother and daughter cells
Investigate dependency on cell polarity pathways
This approach will reveal how GRIP domain proteins like SPAC27D7.02c contribute to Golgi reorganization throughout the cell cycle in S. pombe .
To explore SPAC27D7.02c's role in nutrient stress response in S. pombe, the following experimental strategies can be implemented:
Nutrient limitation studies:
Subject cells to defined media with varying nitrogen sources (ammonium, glutamate, proline)
Monitor SPAC27D7.02c localization, abundance, and modification state using the antibody
Compare results between rich medium (YES) and minimal medium (EMM) conditions
Analyze protein half-life under different nutrient conditions using cycloheximide chase assays
TOR pathway manipulation:
Treat cells with Torin1 to inhibit both TORC1 and TORC2
Analyze changes in SPAC27D7.02c expression and localization
Perform co-immunoprecipitation experiments to identify stress-specific interaction partners
Create genetic interaction maps between SPAC27D7.02c and TOR pathway components
Experimental design table:
| Nutrient Condition | Analysis Method | Key Parameters | Controls |
|---|---|---|---|
| Nitrogen starvation | Western blot | Protein levels, mobility shifts | Wild-type vs. SPAC27D7.02c deletion |
| Carbon limitation | Immunofluorescence | Localization changes | Co-staining with Golgi markers |
| Torin1 treatment | Proteomics | Interaction partners | DMSO-treated controls |
| Amino acid starvation | qPCR | Transcriptional response | Multiple housekeeping genes |
Data integration:
Correlate SPAC27D7.02c behavior with known stress response markers
Compare results with global studies of nutrient-responsive genes
Develop a model for how GRIP domain proteins participate in membrane reorganization during stress
This approach will reveal potential roles of SPAC27D7.02c in adapting membrane trafficking pathways during nutrient fluctuations, which is a critical adaptive response in yeast .
Integrating proteomics with SPAC27D7.02c antibody-based studies provides a comprehensive view of this protein's functional context:
Antibody-facilitated proteomics approaches:
Immunoprecipitation-Mass Spectrometry (IP-MS):
Perform IP using SPAC27D7.02c antibody under various conditions
Analyze precipitated proteins using LC-MS/MS
Apply label-free quantification to determine relative abundances
Use SAINT algorithm to score high-confidence interactions
Proximity-dependent biotinylation:
Create SPAC27D7.02c-BioID fusion protein
Identify proteins in close proximity during different cellular states
Validate key interactions using co-IP with SPAC27D7.02c antibody
Global proteome changes in SPAC27D7.02c mutants:
Compare proteomes of wild-type and SPAC27D7.02c deletion strains
Use SILAC or TMT labeling for accurate quantification
Focus on Golgi and vesicular trafficking pathway components
Integration strategies:
Network analysis:
Build interaction networks using Cytoscape or similar tools
Incorporate data from global S. pombe protein interaction studies
Identify functionally related protein clusters
Subcellular proteome correlation:
Correlate SPAC27D7.02c localization data with subcellular proteomics
Map changes in organelle composition in response to SPAC27D7.02c manipulation
Multi-omics data integration:
Combine proteomics data with transcriptomics studies
Integrate with phosphoproteomics to identify regulatory pathways
Create predictive models of SPAC27D7.02c function in cellular processes
Example workflow:
Identify core SPAC27D7.02c interactors by IP-MS
Map these interactors to cellular pathways
Perform targeted proteomics (MRM/PRM) to quantify pathway components
Validate key findings using SPAC27D7.02c antibody in orthogonal assays
This integrated approach will position SPAC27D7.02c within its functional context and reveal its role in broader cellular processes .
When using SPAC27D7.02c antibody for ChIP experiments in S. pombe, several essential controls must be included:
Critical experimental controls:
Genetic controls:
SPAC27D7.02c deletion strain as negative control
Epitope-tagged SPAC27D7.02c strain for parallel ChIP using anti-tag antibody
Overexpression strain to validate signal enrichment
Antibody specificity controls:
Pre-immune serum or isotype-matched IgG
Peptide competition assay (pre-incubation with immunizing peptide)
Sequential ChIP with another antibody against a known interactor
Technical controls:
Input chromatin (pre-immunoprecipitation sample)
No-antibody control
Non-crosslinked sample control
Mock IP with unrelated antibody
Positive and negative genomic regions:
Amplify known Golgi-associated gene promoters as potential positive regions
Amplify heterochromatic regions as likely negative controls
Include telomeric regions as background controls
Validation approaches:
Perform ChIP-seq followed by peak calling analysis
Validate unexpected chromatin associations with orthogonal methods
Compare binding profiles with transcription factors known to regulate membrane trafficking
Investigate cell cycle-dependent chromatin associations
While GRIP domain proteins are typically not associated with chromatin, this approach allows rigorous testing of any potential nuclear functions of SPAC27D7.02c that might be revealed through antibody-based experiments .
Adapting immunoprecipitation protocols to study post-translational modifications (PTMs) of SPAC27D7.02c requires careful consideration of preservation, enrichment, and detection methods:
Protocol adaptations for PTM analysis:
Lysis buffer modifications:
Include phosphatase inhibitors (50 mM NaF, 10 mM Na₃VO₄, 60 mM β-glycerophosphate)
Add deubiquitinase inhibitors (PR-619, 20 mM N-ethylmaleimide)
Incorporate HDAC inhibitors (sodium butyrate, trichostatin A) for acetylation studies
Use mild detergents (0.5% NP-40) to preserve protein complexes
Specific PTM enrichment strategies:
For phosphorylation: Include phospho-peptide enrichment (TiO₂, IMAC)
For ubiquitination: Use tandem ubiquitin binding entities (TUBEs)
For SUMOylation: Employ SUMO-trap technology
Detection methods:
Immunoblotting with modification-specific antibodies
Mass spectrometry with neutral loss scanning for phosphorylation
Parallel reaction monitoring (PRM) for targeted PTM quantification
Experimental workflow:
| PTM Type | Buffer Additive | Enrichment Strategy | Detection Method |
|---|---|---|---|
| Phosphorylation | Phosphatase inhibitors | Phos-tag gels | MS/MS with neutral loss |
| Ubiquitination | DUB inhibitors | K-ε-GG antibody | Ubiquitin remnant profiling |
| Acetylation | HDAC inhibitors | Anti-acetyllysine antibody | Acetylome analysis |
| Methylation | Methyltransferase inhibitors | Anti-methyllysine antibody | Methylome profiling |
Validation approaches:
Create phospho-mimetic and phospho-dead mutants of key residues
Use CRISPR to introduce PTM-blocking mutations at endogenous loci
Compare PTM profiles under different cellular conditions
Analyze the impact of PTMs on SPAC27D7.02c localization and function
This comprehensive approach will reveal how post-translational modifications regulate SPAC27D7.02c function in various cellular contexts .
Combining CRISPR/Cas9 genome editing with SPAC27D7.02c antibody validation enables sophisticated functional studies:
Integrated experimental approach:
CRISPR/Cas9 modification strategies:
Generate clean gene deletions to create negative controls for antibody specificity
Introduce point mutations in functional domains to study specific protein features
Create endogenous fluorescent protein fusions for correlative microscopy
Engineer auxin-inducible degron tags for rapid protein depletion
Antibody validation in edited strains:
Confirm absence of signal in deletion strains
Validate epitope accessibility in tagged strains
Verify domain-specific antibody recognition in truncation mutants
Assess quantitative correlation between fluorescent tags and antibody signals
Functional dissection workflow:
Map GRIP domain mutations and correlate with localization/function
Create domain swap chimeras with other GRIP proteins
Engineer separation-of-function mutations
Develop rapid protein degradation systems for acute phenotypic analysis
Example experimental design:
| Genetic Modification | Antibody Application | Expected Outcome | Control |
|---|---|---|---|
| Complete gene deletion | Western blot/IF | No signal | Wild-type strain |
| C-terminal point mutations | Western blot | Altered mobility | Wild-type protein |
| GRIP domain deletion | Immunofluorescence | Mislocalization | Full-length protein |
| Endogenous GFP fusion | Co-localization | Signal overlap | Untagged strain |
Advanced applications:
Create a library of domain-specific mutants for structure-function analysis
Perform genetic interaction screens in CRISPR-modified backgrounds
Develop conditional alleles for temperature-sensitive phenotypes
Implement optogenetic control of SPAC27D7.02c localization
This integrated approach allows researchers to fully validate antibody specificity while simultaneously gaining mechanistic insights into SPAC27D7.02c function .
To study SPAC27D7.02c in the context of S. pombe stress responses, researchers can implement these comprehensive strategies:
Stress induction and analysis approaches:
Environmental stress panel:
Oxidative stress (H₂O₂, menadione)
Heat shock (42°C for 15-30 minutes)
Osmotic stress (1M sorbitol or 0.6M KCl)
DNA damage (UV, MMS, or phleomycin)
ER stress (DTT or tunicamycin)
Temporal analysis framework:
Acute response (5-30 minutes after stress)
Adaptation phase (1-3 hours)
Recovery period (post-stress removal)
Preconditioning experiments (mild followed by severe stress)
Multi-level analysis:
Protein abundance by quantitative Western blotting
Subcellular relocalization by immunofluorescence
Post-translational modifications via IP-MS
Altered protein interactions through comparative Co-IP
Transcriptional regulation using RT-qPCR
Experimental design matrix:
| Stress Type | Primary Assays | Secondary Validation | Control Conditions |
|---|---|---|---|
| Oxidative | Western blot, localization | Phosphorylation analysis | Sty1 pathway activity |
| Nutritional | Co-IP, abundance | Golgi morphology changes | TOR pathway inhibition |
| Thermal | Protein solubility | Chaperone interactions | Heat shock response markers |
| Cell wall | Secretion assays | Glycosylation analysis | Cell wall integrity pathway |
Integrated data analysis:
Compare SPAC27D7.02c responses across stress types
Identify common regulatory mechanisms
Correlate with global stress response datasets
Map to specific stress response pathways
This systematic approach will reveal how SPAC27D7.02c participates in cellular adaptation to diverse stresses, potentially uncovering novel functions beyond its predicted Golgi-related activities .
Developing and validating phospho-specific antibodies for SPAC27D7.02c requires a systematic approach:
Development strategy:
Phosphorylation site identification:
Perform phosphoproteomics analysis of S. pombe cells
Analyze SPAC27D7.02c sequence for predicted kinase motifs
Compare with phosphorylation sites in homologous proteins
Focus on evolutionary conserved residues within functional domains
Antibody generation approach:
Design phosphopeptide antigens (10-15 amino acids with phosphorylated residue centrally positioned)
Consider both polyclonal and monoclonal antibody production
Develop multiple antibodies against different phospho-sites
Use non-phosphorylated peptides for negative selection
Purification strategy:
Employ tandem affinity purification with phospho-peptide columns
Remove non-phospho-specific antibodies
Positively select with phospho-peptides
Perform ELISA-based titration to determine specificity
Validation framework:
| Validation Method | Purpose | Expected Result | Control |
|---|---|---|---|
| Western blot | Basic specificity | Signal in wild-type, absent in phospho-mutant | Lambda phosphatase treatment |
| Peptide competition | Epitope specificity | Signal blocked by phospho-peptide | Non-phospho-peptide control |
| Immunofluorescence | Spatial detection | Changed localization after kinase activation | Phospho-mutant strain |
| Kinase manipulation | Functional validation | Increased signal after kinase activation | Kinase inhibition |
Application examples:
Track phosphorylation dynamics during cell cycle progression
Study phosphorylation changes during Golgi fragmentation and reassembly
Investigate kinase-dependent regulation of SPAC27D7.02c function
Map phosphorylation-dependent protein interactions